Regenxbio
RGNX
48 hedge funds and large institutions have $310M invested in Regenxbio in 2015 Q3 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$78.5M |
| 2 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$49.4M |
| 3 |
DM
Deerfield Management
New York
|
+$34.1M |
| 4 |
VM
VHCP Management
New York
|
+$27.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$25.1M |
Top Sellers
RGNX Hedge Fund Activity: Q3 2015 in Review
48 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q3 2015, worth a combined $310M.
Buyers outnumbered sellers: 48 funds opened new RGNX positions and 0 closed out — a net gain of 48 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $78.5M.
- 48 institutional investors held Regenxbio (RGNX) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $310M of Regenxbio stock for Q3 2015.
- 48 funds opened new Regenxbio positions in Q3 2015 and 0 closed out, a net change of +48 holders.
- The largest Regenxbio buyer in Q3 2015 was Fidelity Investments, an estimated $78.5M added.
Based on aggregated 13F filings for Q3 2015.